glp-1 and eyesight 💉 Optometrists are warning drugs may pose these types of rare risks 💉 ⬇️ Details in comments Does GLP-1 Cause Eye Problems?

Weight-loss medications may be covered for individuals whose BMI is 35 or greater, or 30 and above with a qualifying health condition like diabetes, hypertension, or dyslipidemia

Avoid comparing timeline, side effects, or rate of loss to your first round

Ponirakis G, Abdul-Ghani MA, Jayyousi A, Zirie MA, Qazi M, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, Al-Mohannadi S, AlMarri F, Al-Khayat F, Mahfoud Z, Al Hamad H, Ramadan M, DeFronzo R, Malik RA (2021) Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control

Taylor starts low, goes slow, and adjusts your plan to keep you comfortable

Begum F, Chang K, Kapoor K, et al

If development started today, oral tirzepatide would likely require 6-11 years to reach FDA approval (typical pharmaceutical development timeline)